Brief: RhoVac Ends Collaboration With Colpman Consulting
Dec 2 (Reuters) - RhoVac AB RHOVAC.TE :
* RHOVAC ENDS THE COLLABORATION WITH COLPMAN CONSULTING LTD
* COLLABORATION AGREEMENT WITH COLPMAN CONSULTING LTD
("COLPMAN
LTD") HAS BEEN TERMINATED BY MUTUAL AGREEMENT, IN LIGHT OF
RHOVAC'S AIM TO SECURE AN AGREEMENT WITH A PARTNER AFTER
COMPLETION OF CURRENT CLINICAL PHASE IIB STUDY
Source text for Eikon: ID:nWkr82YYNp
Further company coverage: RHOVAC.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Chosa Oncology AB
See all newsBrief: Chosa Oncology Appoints Gerton Jönsson As New Chief Financial Officer
Brief: CHOSA Oncology AB Says Postpones Publication Of Interim Report Q4 2024
Brief: Chosa Oncology Carried Out Directed Issue Of Sek 1,55 Mln To Further Increase Business Development Activities
Brief: Chosa Oncology Announces Decision To Postpone Release Of Interim Report For Q2 2023
Brief: Chosa Oncology AB Publishes Results From Clinical Phase 2 Trial Of Liposomal Formulation In Breast Cancer, Using Predictive Marker For Cisplatin